Tarsus Pharmaceuticals, Inc. (TARS)
80.28
+3.39
(+4.41%)
USD |
NASDAQ |
Nov 13, 16:00
80.40
+0.12
(+0.15%)
After-Hours: 19:59
Tarsus Pharmaceuticals Profit Margin (Quarterly) : -343.5% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -343.5% |
| June 30, 2026 | -10.67% |
| March 31, 2026 | -4.30% |
| December 31, 2025 | -5.52% |
| September 30, 2025 | -10.60% |
| June 30, 2025 | -19.81% |
| March 31, 2025 | -32.07% |
| December 31, 2024 | -34.80% |
| September 30, 2024 | -48.67% |
| June 30, 2024 | -81.57% |
| March 31, 2024 | -129.4% |
| December 31, 2023 | -320.4% |
| Date | Value |
|---|---|
| September 30, 2023 | -2.09K% |
| June 30, 2023 | |
| March 31, 2023 | -936.8% |
| December 31, 2022 | -136.0% |
| September 30, 2022 | |
| June 30, 2022 | -37.59% |
| March 31, 2022 | -3.75K% |
| December 31, 2021 | -4.39K% |
| September 30, 2021 | -1.27K% |
| June 30, 2021 | 28.61% |
| March 31, 2021 | 30.77% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 16.53% |
| Amneal Pharmaceuticals, Inc. | 1.43% |
| Harmony Biosciences Holdings, Inc. | 17.92% |
| ANI Pharmaceuticals, Inc. | 11.25% |
| Corcept Therapeutics, Inc. | 36.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -237.5% |
| Return on Assets | -125.4% |
| Return on Invested Capital | -183.9% |
| Gross Profit Margin (Quarterly) | 92.86% |
| Operating Margin (Quarterly) | -16.21% |
| Return on Net Operating Assets | -468.5% |